Insider Transactions in Q3 2024 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Shalini Sharp Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,151
+50.0%
|
-
|
|
Sep 30
2024
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,202
-100.0%
|
$284,874
$237.1 P/Share
|
|
Sep 27
2024
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
5,000
-100.0%
|
$1,100,000
$220.35 P/Share
|
|
Sep 19
2024
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
4,500
-100.0%
|
$900,000
$200.14 P/Share
|
|
Sep 17
2024
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
500
-10.0%
|
$100,000
$200.0 P/Share
|
|
Sep 03
2024
|
Titus B. Ball Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
137
-100.0%
|
$25,893
$189.94 P/Share
|
|
Sep 03
2024
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
5,556
-57.25%
|
$1,055,640
$190.13 P/Share
|
|
Aug 12
2024
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
301,457
-5.41%
|
-
|
|
Aug 09
2024
|
Aaron Rosenberg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,547
+50.0%
|
-
|
|
Jul 30
2024
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
834
-100.0%
|
$133,440
$160.57 P/Share
|
|
Jul 01
2024
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
472
-100.0%
|
$67,496
$143.9 P/Share
|